NEW YORK (GenomeWeb News) – Bio-Rad Laboratories and Inpeco today announced a deal to build interfaces between Bio-Rad's clinical diagnostics platforms and Inpeco's FlexLab system.

The deal covers Bio-Rad's systems for diabetes, autoimmune disease, and infectious disease testing, and aims to provide clinical diagnostics labs "a complete and integrated solution that automates sample processing, consolidates testing platforms, and improves operating efficiency of the instruments," the partners said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Five researchers are to share this year's Albany Medical Center Prize for their work on the CRISPR/Cas9 gene-editing tool, the AP reports.

Stat News reports on how white supremacists cope with surprising genetic ancestry testing results.

In Genome Research this week: sex-biased gene expression evolution in malaria mosquitos, method to find ancient selective sweeps, and more.

Iceland has nearly eliminated Down syndrome from its population, CBS News reports.